Acute myocardial infarction

Never a good time, but some times are better than others

[1]  Kristine M. Thompson,et al.  Off-hour presentation and outcomes in patients with acute myocardial infarction: systematic review and meta-analysis , 2014, BMJ : British Medical Journal.

[2]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[3]  A. Deodhar,et al.  Pregabalin for fibromyalgia: Some relief but no cure , 2009, Cleveland Clinic Journal of Medicine.

[4]  Ismael R Ortega-Sanchez,et al.  Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2008, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[5]  A. Gitt,et al.  Influence of presentation at the weekend on treatment and outcome in ST-elevation myocardial infarction in hospitals with catheterization laboratories , 2008, Clinical Research in Cardiology.

[6]  Alan C. Wilson,et al.  Weekend versus weekday admission and mortality from myocardial infarction. , 2007, The New England journal of medicine.

[7]  S. Mackey,et al.  A vaccine to prevent herpes zoster. , 2005, The New England journal of medicine.

[8]  B. Lewis,et al.  Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. , 2005, JAMA.

[9]  H. Krumholz,et al.  Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. , 2005, JAMA.

[10]  S. Yusuf,et al.  Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. , 2005, JAMA.

[11]  R. Califf,et al.  Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction. , 1996, The American journal of cardiology.

[12]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.